Cardiol Operating Income from 2010 to 2026
| CRDL Stock | CAD 1.37 0.02 1.48% |
Operating Income | First Reported 2017-06-30 | Previous Quarter -7.7 M | Current Value -10.2 M | Quarterly Volatility 4.2 M |
Check Cardiol Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cardiol Therapeutics' main balance sheet or income statement drivers, such as Net Interest Income of 1.4 M, Interest Income of 3 M or Depreciation And Amortization of 218.2 K, as well as many indicators such as Price To Sales Ratio of 1 K, Dividend Yield of 0.0 or PTB Ratio of 8.31. Cardiol financial statements analysis is a perfect complement when working with Cardiol Therapeutics Valuation or Volatility modules.
Cardiol | Operating Income |
Latest Cardiol Therapeutics' Operating Income Growth Pattern
Below is the plot of the Operating Income of Cardiol Therapeutics Class over the last few years. Operating Income is the amount of profit realized from Cardiol Therapeutics operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Cardiol Therapeutics Class is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. Cardiol Therapeutics' Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cardiol Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| Operating Income | 10 Years Trend |
|
Operating Income |
| Timeline |
Cardiol Operating Income Regression Statistics
| Arithmetic Mean | (17,331,291) | |
| Coefficient Of Variation | (106.52) | |
| Mean Deviation | 16,408,492 | |
| Median | (7,493,739) | |
| Standard Deviation | 18,461,408 | |
| Sample Variance | 340.8T | |
| Range | 48.7M | |
| R-Value | (0.86) | |
| Mean Square Error | 94.2T | |
| R-Squared | 0.74 | |
| Slope | (3,146,957) | |
| Total Sum of Squares | 5453.2T |
Cardiol Operating Income History
About Cardiol Therapeutics Financial Statements
Cardiol Therapeutics investors utilize fundamental indicators, such as Operating Income, to predict how Cardiol Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Operating Income | -36.2 M | -38.1 M |
Check out the analysis of Cardiol Therapeutics Correlation against competitors. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.